Zimmer Biomet Holdings Inc (NYSE:ZBH) has been given a “BBB+” credit rating by Morningstar. The firm’s “BBB+” rating suggests that the company is a moderate default risk. They also gave their stock a four star rating. In other Zimmer Biomet Holdings news, CEO David C. Dvorak sold 44,661 shares of the firm’s stock in a […]
